BIGG

Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

Wedzicha, JA; Calverley, PMA; Albert, RK; Anzueto, A; Criner, GJ; Hurst, JR; Miravitlles, M; Papi, A; Rabe, KF; Rigau, D; Sliwinski, P; Tonia, T; Vestbo, J; Wilson, KC; Krishnan, JA.

Eur. respir. j; 50 (3), 2017

This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...

Agonistas de Receptores Adrenérgicos beta 2/uso terapéutico, Aminopiridinas/uso terapéutico, Benzamidas/uso terapéutico, Ciclopropanos/uso terapéutico, Fluoroquinolonas/uso terapéutico, Macrólidos/uso terapéutico, Antagonistas Muscarínicos/uso terapéutico, Inhibidores de Fosfodiesterasa 4/uso terapéutico, Progresión de la Enfermedad, Enfermedad Pulmonar Obstructiva Crónica, Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico, Enfermedad Pulmonar Obstructiva Crónica/fisiopatología, Prevención Secundaria/normas, Agonistas de Receptores Adrenérgicos beta 2, Aminopiridinas, Benzamidas, Ciclopropanos, Fluoroquinolonas, Macrólidos, Antagonistas Muscarínicos, Inhibidores de Fosfodiesterasa 4

Texto completo

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studi...